BSX vs ECVT · P/E 20, rev $16.75B vs rev $704.5M
Boston Scientific Corp (BSX) versus Ecovyst Inc (ECVT) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Ecovyst Inc (ECVT) is a specialty chemicals company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported ECVT revenue for 2024-12-31 was $704.5M. Net income was -$6.7M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. ECVT currently screens at market cap $892.2M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. ECVT currently screens at market cap $892.2M.
Not investment advice. Open the BSX and ECVT stock pages for the full models.
Not investment advice.